|
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents
|
Apr 2023
|
Current Hematologic Malignancy Reports
|
myelodysplastic syndromes (MDS)
|
|
Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.
|
Jun 2013
|
J Exp Med
|
aplastic anemia
|
|
The value of survival gains in myelodysplastic syndromes.
|
Jan 2017
|
Am J Manag Care
|
myelodysplastic syndromes (MDS)
|
|
The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes
|
May 2015
|
Int J Lab Hematol
|
myelodysplastic syndromes (MDS)
|
|
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells
|
Feb 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers
|
Dec 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
|
Sep 2013
|
Adv Biol Regul
|
myelodysplastic syndromes (MDS)
|
|
The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications
|
Dec 2016
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
|
Oct 2013
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes
|
May 2023
|
Frontiers in Oncology
|
aplastic anemia
|
